Medicrea International SA organizacji EV/Sales
Jaka jest wartość EV/Sales organizacji Medicrea International SA?
Wartość EV/Sales organizacji Medicrea International SA to 7.55
Jaka jest definicja EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales firm w Health Care sektor na LSE w porównaniu do Medicrea International SA
Czym się zajmuję organizacja Medicrea International SA?
Medicrea International SA designs, manufactures, and distributes spinal implants in France and internationally. It offers PASS range, a polyaxial spine system; PASS LP, a thoraco-lumbar fixation system; LigaPASS, a band connector for posterior thoracolumbar fixation; PASS TULIP, a top loading posterior fixation system; PASS DEGEN for thoracic and lumbar degenerative indications; PASS OCT, an occipito-cervico-thoracic fixation system; PASS MIS, a posterior anchoring system; PASS Antérieur that offers a range of specific implants enabling surgery using an anterior approach; IMPIX C, a sterile PEEK Optima cervical interbody device; IMPIX-C+, a sterile PEEK Optima cervical interbody device that is prefilled with bone substitute; and IMPIX-MANTA, a sterile PEEK Optima cervical interbody device that is preassembled on holder/ impactor and delivers with a disposable instrumentation kit. Its implants for cervical spine also include IMPIX-MANTA +, a sterile PEEK Optima cervical interbody device, which is prefilled with synthetic bone substitutes; and GRANVIA-C, a MRI compatible ceramic cervical disc. In addition, it provides implants for the thoracic and lumbar spine, such as IMPIX-L, a sterile PEEK Optima lumbar interbody device for posterior approach; IMPIX-TLIF, a sterile PEEK Optima lumbar interbody device for transforaminal approach with a pre-assembled PEEK control lead; IMPIX-ALIF, a sterile PEEK Optima lumbar interbody device for anterior approach; STABOLT, an anatomically-shaped anterior plate; OSMOSYS, a macroporous bone substitute; IMPIX-DLIF and IMPIX-DLIF SLIM sterile PEEK Optima lumbar interbody devices for direct or oblique lateral approach; and X-JAWS, a titanium lumbar staple to secure a lateral or an anterior cage. Its implants are designed to treat scoliosis, degenerative diseases, malformations, trauma, and tumors; and used in various traditional and surgical procedures. The company was founded in 1990 and is headquartered in Rillieux-la-Pape, France.
Firmy z ev/sales podobne do Medicrea International SA
- Wartość EV/Sales organizacji Desktop Metal to 7.52
- Wartość EV/Sales organizacji CStone Pharmaceuticals to 7.52
- Wartość EV/Sales organizacji Yunnan Water Investment Co to 7.53
- Wartość EV/Sales organizacji Bharti Airtel to 7.53
- Wartość EV/Sales organizacji Freshpet Inc to 7.54
- Wartość EV/Sales organizacji Yew Grove REIT plc to 7.55
- Wartość EV/Sales organizacji Medicrea International SA to 7.55
- Wartość EV/Sales organizacji Panda Green to 7.56
- Wartość EV/Sales organizacji Ruffer Investment Co to 7.56
- Wartość EV/Sales organizacji NextEra Partners LP to 7.56
- Wartość EV/Sales organizacji The Western Investment of Canada to 7.56
- Wartość EV/Sales organizacji Fiducial Real Estate SA to 7.57
- Wartość EV/Sales organizacji Slate Office REIT to 7.57